Toshikazu Abe Selected Research

Toshikazu Abe Research Topics

Disease

31	Sepsis (Septicemia) 03/2024 - 11/2017
15	Wounds and Injuries (Trauma) 11/2023 - 09/2009
10	Disseminated Intravascular Coagulation 03/2023 - 06/2019
8	Septic Shock (Toxic Shock Syndrome) 01/2023 - 11/2019
5	Infections 12/2023 - 01/2020
5	COVID-19 04/2023 - 03/2021
5	Hemorrhage 01/2023 - 01/2021
5	Heart Arrest (Cardiac Arrest) 01/2022 - 04/2009
5	Multiple Organ Failure (MODS) 01/2022 - 01/2018
3	Out-of-Hospital Cardiac Arrest 03/2023 - 01/2020
3	Hemorrhagic Shock 01/2022 - 12/2018
2	Bronchiectasis 01/2024 - 05/2023
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2023 - 01/2018
2	Shock 03/2023 - 01/2022
2	Frailty 08/2021 - 01/2021
2	Hypothermia 05/2020 - 01/2019
2	Thrombosis (Thrombus) 11/2019 - 09/2019
2	Respiratory Insufficiency (Respiratory Failure) 01/2018 - 01/2014
2	Neoplasms (Cancer) 12/2003 - 02/2003
1	Subcutaneous Emphysema 01/2024
1	Hyperoxia 12/2023
1	Thrombocytopenia (Thrombopenia) 11/2023
1	Mycoses (Diseases, Fungus) 04/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Acute Aortic Syndrome 01/2023
1	Chronic Disease (Chronic Diseases) 07/2022
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2022
1	Burns 11/2021
1	Hyperglycemia 10/2021
1	Open Fractures (Compound Fracture) 01/2021
1	Spinal Injuries (Spinal Injury) 01/2021
1	Acute Lung Injury 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Heart Failure 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Tics (Tic) 01/2020
1	Diabetes Mellitus 01/2020

Drug/Important Bio-Agent (IBA)

10	Dacarbazine (DIC)FDA LinkGeneric 03/2023 - 06/2019
6	AnticoagulantsIBA 11/2023 - 11/2019
5	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 06/2009
4	Vasopressins (Vasopressin)IBA 01/2023 - 11/2019
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2019
3	AntithrombinsIBA 01/2022 - 09/2019
3	ThrombomodulinIBA 01/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 12/2023 - 07/2019
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023 - 01/2021
2	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2021
2	FibrinIBA 08/2022 - 01/2022
2	Thrombin FDA Link 01/2022 - 01/2020
2	Complement System Proteins (Complement)IBA 05/2020 - 11/2017
2	SteroidsIBA 01/2020 - 01/2014
2	Epinephrine (Adrenaline)FDA LinkGeneric 11/2019 - 01/2019
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2024
1	Third Generation CephalosporinsIBA 03/2024
1	tetraethylpyrazine (TEP)IBA 11/2023
1	Insulin (Novolin)FDA Link 04/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2023
1	Methylprednisolone FDA LinkGeneric 04/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2023
1	A-factor (Streptomyces)IBA 03/2023
1	Tranexamic Acid (AMCA)FDA Link 08/2022
1	estropipate (Ogen)FDA LinkGeneric 08/2022
1	Vitamin K FDA Link 01/2022
1	nafamostatIBA 12/2021
1	Dexmedetomidine FDA Link 11/2021
1	Midazolam (Versed)FDA LinkGeneric 11/2021
1	Propofol (Diprivan)FDA LinkGeneric 11/2021
1	Hypnotics and Sedatives (Sedatives)IBA 11/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2021
1	formycin diphosphate (FDP)IBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	EndotoxinsIBA 11/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 11/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020

Therapy/Procedure

14	Therapeutics 03/2024 - 06/2009
7	Resuscitation 01/2022 - 12/2016
5	Length of Stay 07/2022 - 05/2006
4	Critical Care (Surgical Intensive Care) 12/2023 - 01/2020
4	Cardiopulmonary Resuscitation (CPR) 03/2023 - 01/2011
4	Blood Transfusion (Blood Transfusions) 01/2023 - 12/2018
3	Artificial Respiration (Mechanical Ventilation) 03/2022 - 01/2020
3	Patient Care Bundles 01/2022 - 11/2019
2	Traction 01/2024 - 05/2023
2	Extracorporeal Membrane Oxygenation 05/2023 - 12/2022
2	Nephroureterectomy 12/2003 - 02/2003
1	Splenectomy 11/2023
1	Defibrillators (Defibrillator) 03/2023
1	Artificial Organs (Artificial Organ) 01/2023
1	Airway Management 01/2023
1	Intravenous Administration 01/2023
1	Thoracotomy 01/2022
1	Glycemic Control 10/2021
1	Long-Term Care 03/2021
1	Catheters 01/2021
1	Hemoperfusion 11/2020
1	Percutaneous Coronary Intervention 11/2019